Research in the Nucmed group focuses on the development of novel tracers to image disease processes using radionuclide and optical imaging techniques.
The main areas of interest are cancer, diabetes, rheumatoid arthritis, and neurological disorders. In addition, for certain applications, these tracers are used as therapeutic agents as well. Our translational research lines start with tracer development, followed by preclinical characterization in animal models and finally clinical studies are carried out in patients. Please click here for an overview of all projects.